Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer

• المؤلفون الرئيسيون: Jitawatanarat,P., O’connor,T.L., Kossoff,E.B., Levine,E.G., Chittawatanarat,K., Ngamphaiboon,N.
• التنسيق: مقال
• منشور في: Korean Breast Cancer Society 2015
• الموضوعات: Cancer Research; Oncology
• الوصول للمادة أونلاين: http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84919832059&origin=inward; http://cmuir.cmu.ac.th/handle/6653943832/38356

© 2014 Korean Breast Cancer Society. All rights reserved. Purpose: We evaluated the tolerability and cardiac safety of docetaxel, cyclophosphamide, and trastuzumab (TCyH) for the treatment of early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer and compared to the stand...